The Valley Desk

NCT03191149 · Interventional trial

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Overall registry status Recruiting

Phase 2

Conditions Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Non-Small Cell Cancer AJCC v7, Stage IV Lung Non-Small Cell Cancer AJCC v7

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov